LIVN
LivaNova PLC
NASDAQ: LIVN · HEALTHCARE · MEDICAL DEVICES
$58.92
-3.87% today
Updated 2026-04-29
Market cap
$3.51B
P/E ratio
—
P/S ratio
2.53x
EPS (TTM)
$-4.45
Dividend yield
—
52W range
$35 – $72
Volume
0.9M
WallStSmart proprietary scores
48
out of 100
Grade: C
Sell
Investment rating
5.3
Growth
C+4.5
Quality
C4.0
Profitability
C7.7
Valuation
B+3/9
Piotroski F-Score
Weak
0.8
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
$79.18
+34.39%
12-Month target
—
—
Intrinsic (DCF)
$102.04
Margin of safety
+34.90%
2 Strong Buy6 Buy3 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ Free cash flow $50.20M — positive
+ Revenue growth 12.10% QoQ
+ 34.90% below intrinsic value
+ Debt/equity 0.42x — low leverage
Risks
- Piotroski 3/9 — weak financial health
- Altman Z 0.84 — distress zone
- Thin margins at -17.50%
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $1.02B | $1.15B | $1.25B | $1.39B | $1.39B |
| Net income | $-86.25M | $17.55M | $63.23M | $-242.50M | $30.88M |
| EPS | — | — | — | — | $-4.45 |
| Free cash flow | $43.40M | $39.93M | $135.93M | $173.20M | $50.20M |
| Profit margin | -8.44% | 1.52% | 5.04% | -17.47% | -17.50% |
Peer comparison
Smart narrative
LivaNova PLC trades at $58.92. Our Smart Value Score of 48/100 indicates the stock is fair. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of 0.84, it sits in the distress. TTM revenue stands at $1.39B. with profit margins at -17.50%. Our DCF model estimates intrinsic value at $102.04.
Frequently asked questions
What is LivaNova PLC's stock price?
LivaNova PLC (LIVN) trades at $58.92.
Is LivaNova PLC overvalued?
Smart Value Score 48/100 (Grade C, Sell). DCF value $102.04.
What is the price target of LivaNova PLC (LIVN)?
The analyst target price is $79.18, representing +34.4% upside from the current price of $58.92.
What is the intrinsic value of LivaNova PLC (LIVN)?
Based on our DCF model, intrinsic value is $102.04, a +34.9% margin of safety versus $58.92.
What is LivaNova PLC's revenue?
TTM revenue is $1.39B.
Piotroski F-Score?
3/9 — weak financial health.
Altman Z-Score?
0.84 — distress.
Company info
SectorHEALTHCARE
IndustryMEDICAL DEVICES
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio2.53x
ROE-19.20%
Beta0.97
50D MA$64.72
200D MA$58.17
Shares out0.05B
Float0.05B
Short ratio—
Avg volume0.9M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—